PRESS DIGEST- Wall Street Journal – Sept 14


Sept 14 (Reuters) – The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

– President Donald Trump signed an executive order on Sunday to reduce the cost of prescription drugs for U.S. seniors by more closely aligning prices with what pharmaceutical companies charge in other countries. https://on.wsj.com/3kjdMev

– Oracle Corp won the bidding for the U.S. operations of the video-sharing app TikTok, people familiar with the matter said, beating out Microsoft Corp in a high-profile deal to salvage a social-media sensation that has been caught in the middle of a geopolitical standoff. https://on.wsj.com/3ml1pQX

– Gilead Sciences Inc will pay $21 billion to buy biotech Immunomedics Inc and its prized breast-cancer drug, the company said Sunday, a sign of the value of the cancer-drugs business. https://on.wsj.com/33trc0G

– AstraZeneca Plc said Saturday clinical trials for its experimental coronavirus vaccine have resumed in the U.K. after regulators concluded it was safe to do so, following a pause in studies globally after a person who received the vaccine had an unexplained illness. https://on.wsj.com/2GYlzjL (Compiled by Bengaluru newsroom)

Read More